Catheter-related bloodstream infections: catheter management according to pathogen

Int J Antimicrob Agents. 2010 Dec:36 Suppl 2:S26-32. doi: 10.1016/j.ijantimicag.2010.11.004. Epub 2010 Dec 3.

Abstract

Central-line access is an essential part of modern healthcare practice; however, catheter-related bloodstream infection is a major problem that causes substantial morbidity and mortality, and excess length of stay and cost. The risk of infection depends on the type of device, the site of insertion, the underlying conditions and the appropriate prevention measures taken during catheter insertion. Management of catheter-related bloodstream infection involves deciding on catheter removal, antimicrobial catheter lock solution and the type and duration of systemic antimicrobial therapy. Systemic antimicrobial use is essential but, although generally effective in controlling sepsis, it often fails to sterilise the line, increasing the incidence of complications or recurrence. The decision regarding whether the catheter should be removed or retained is therefore crucial. One of the major factors to be considered is the type of organism involved in the catheter-related infection. This review outlines the epidemiology, pathogenesis, diagnosis, microbiology and management of catheter-related infections, mainly focusing on the management of the intravascular device according to the pathogen.

Publication types

  • Review

MeSH terms

  • Anti-Infective Agents / therapeutic use
  • Catheter-Related Infections / drug therapy*
  • Catheter-Related Infections / microbiology
  • Catheterization / adverse effects*
  • Catheterization, Central Venous / adverse effects*
  • Humans
  • Sepsis / drug therapy*
  • Sepsis / microbiology

Substances

  • Anti-Infective Agents